Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 247.74%1.8M | -122.93%-1.88M | -278.24%-3.01M | -33.60%12.34M | -12.50%3.67M | -1.22M | 8.19M | 1.69M | 23.03%18.58M | -29.06%4.2M |
| Net profit before non-cash adjustment | -138.77%-776K | -248.91%-1.63M | -117.20%-482K | -74.28%2.47M | -162.04%-1.1M | ---325K | --1.1M | --2.8M | 30.90%9.61M | 19.06%1.78M |
| Total adjustment of non-cash items | -22.41%1.69M | 24.73%2.04M | 58.94%1.72M | -6.21%5.76M | -60.92%860.24K | --2.18M | --1.64M | --1.08M | -15.85%6.14M | -19.09%2.2M |
| -Depreciation and amortization | 8.57%1.7M | 6.30%1.65M | 0.00%1.55M | 1.97%6.14M | -6.37%1.46M | --1.56M | --1.56M | --1.55M | 3.41%6.02M | 8.44%1.56M |
| -Reversal of impairment losses recognized in profit and loss | -90.91%1K | --0 | --2K | 200.98%74.27K | 19,627.47%63.27K | --11K | ---- | ---- | -25.22%24.68K | -101.25%-324 |
| -Disposal profit | 63.16%-42K | -290.63%-125K | 43.45%-82K | -82.26%-352.25K | -89.83%-61.25K | ---114K | ---32K | ---145K | -7.37%-193.26K | -29.06%-32.26K |
| -Net exchange gains and losses | -108.24%-59K | 507.14%425K | 140.04%185K | 36.90%-314.72K | -220.69%-638.72K | --716K | --70K | ---462K | -216.81%-498.79K | -45.83%529.21K |
| -Other non-cash items | 1,800.00%95K | 102.27%89K | -57.58%56K | -72.87%213.81K | -76.74%32.81K | --5K | --44K | --132K | -34.11%788.05K | -53.14%141.05K |
| Changes in working capital | 128.74%884K | -141.95%-2.29M | -93.93%-4.25M | 45.05%4.11M | 1,662.72%3.91M | ---3.08M | --5.46M | ---2.19M | 509.05%2.83M | -86.99%222.1K |
| -Change in receivables | 93.36%-297K | -83.81%1.05M | -4,520.34%-2.73M | 1,106.03%6.47M | 336.45%4.55M | ---4.47M | --6.46M | ---59K | -20.61%536.66K | 1,125.48%1.04M |
| -Change in inventory | 44.72%-110K | -291.80%-234K | -122.22%-62K | -155.40%-369.29K | -568.56%-571.29K | ---199K | --122K | --279K | 267.90%666.55K | -129.47%-85.45K |
| -Change in payables | -16.32%1.33M | -184.08%-3.18M | 39.46%-1.46M | -222.48%-1.99M | 91.83%-60K | --1.59M | ---1.12M | ---2.41M | 775.75%1.63M | -155.11%-734.11K |
| -Changes in other current assets | ---42K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -21.49%-147K | -7.19%-164K | 24.85%-127K | 39.18%-556.33K | 36.58%-113.33K | -121K | -153K | -169K | 14.52%-914.69K | 43.45%-178.69K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 100.12%1K | 58.88%-331K | 72.17%-280K | -115.45%-2.65M | 96.93%-39.35K | -804K | -805K | -1.01M | 37.46%-1.23M | -4,317.32%-1.28M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 177.19%1.66M | -132.81%-2.37M | -762.98%-3.42M | -44.46%9.13M | 28.55%3.52M | ---2.14M | --7.24M | --516K | 36.24%16.44M | -50.86%2.74M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 5.07%-1.42M | 66.78%-1.23M | -290.24%-2.24M | -453.94%-10.61M | -761.57%-4.83M | ---1.5M | ---3.7M | ---574K | 63.25%-1.91M | 70.54%-560.88K |
| Net investment product transactions | -41.67%28K | 40.63%45K | 48.78%61K | 1,617.10%159.12K | --38.12K | --48K | --32K | --41K | --9.27K | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | -45.83%52K | -31.19%75K | 91.89%71K | 165.97%323.21K | 122.35%81.21K | --96K | --109K | --37K | 84.13%121.53K | 102.92%36.53K |
| Investing cash flow | 0.89%-1.34M | 68.84%-1.11M | -325.00%-2.11M | -467.52%-10.13M | -814.99%-4.71M | ---1.35M | ---3.56M | ---496K | 65.09%-1.78M | 72.69%-515.09K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -104.98%-221K | 61.55%-1.68M | 855.32%3.68M | 104.20%412.83K | -135.08%-50.17K | --4.44M | ---4.36M | --385K | -823.62%-9.83M | -93.17%143.03K |
| Net common stock issuance | --0 | --0 | -88.63%1.59M | --14M | --0 | --0 | --0 | --14M | --0 | --0 |
| Increase or decrease of lease financing | 4.27%-112K | 86.13%-110K | 83.46%-109K | 34.06%-1.69M | 81.91%-118.22K | ---117K | ---793K | ---659K | 12.16%-2.56M | 29.26%-653.66K |
| Issuance fees | --0 | --0 | 96.78%-34K | ---1.06M | ---361 | --0 | --0 | ---1.06M | --0 | ---- |
| Cash dividends paid | ---- | ---- | ---- | ---4.2M | --0 | --0 | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7.06K | ---- |
| Financing cash flow | -107.70%-333K | 80.90%-1.79M | -59.53%5.13M | 160.24%7.47M | 67.40%-168.75K | --4.32M | ---9.36M | --12.67M | -172.28%-12.4M | 71.73%-517.69K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.11%10.76M | -29.74%16.4M | 59.73%16.85M | 32.26%10.55M | 114.80%18.3M | --17.68M | --23.34M | --10.55M | 43.04%7.97M | 39.27%8.52M |
| Current changes in cash | -102.42%-20K | 7.23%-5.27M | -103.17%-402K | 187.49%6.47M | -179.74%-1.36M | --825K | ---5.68M | --12.69M | -6.16%2.25M | -8.12%1.71M |
| Effect of exchange rate changes | 93.20%-14K | -2,015.79%-364K | -141.51%-44K | -153.75%-172.28K | ---91.28K | ---206K | --19K | --106K | --320.49K | ---- |
| End cash Position | -41.36%10.73M | -39.11%10.76M | -29.74%16.4M | 59.74%16.85M | 59.74%16.85M | --18.3M | --17.68M | --23.34M | 32.26%10.55M | 32.26%10.55M |
| Free cash flow | 105.90%219K | -204.90%-3.71M | -3,394.44%-5.66M | -111.68%-1.67M | -161.89%-1.33M | ---3.71M | --3.53M | ---162K | 115.06%14.34M | -40.87%2.16M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.